APA (7th ed.) Citation

URSU, R., Doridam, J., Chaugne, E., Zannou, H., Belin, C., Cuzzubbo, S., . . . Carpentier, A. (2019). P14.31 CMV reactivation in a cohort of newly-diagnosed glioblastoma patients treated with temozolomide chemoradiotherapy. A single center analysis. Neuro-oncology, 21, iii73. https://doi.org/10.1093/neuonc/noz126.266

Chicago Style (17th ed.) Citation

URSU, R., et al. "P14.31 CMV Reactivation in a Cohort of Newly-diagnosed Glioblastoma Patients Treated with Temozolomide Chemoradiotherapy. A Single Center Analysis." Neuro-oncology 21 (2019): iii73. https://doi.org/10.1093/neuonc/noz126.266.

MLA (9th ed.) Citation

URSU, R., et al. "P14.31 CMV Reactivation in a Cohort of Newly-diagnosed Glioblastoma Patients Treated with Temozolomide Chemoradiotherapy. A Single Center Analysis." Neuro-oncology, vol. 21, 2019, p. iii73, https://doi.org/10.1093/neuonc/noz126.266.